As of 2025-12-11, the Intrinsic Value of Olema Pharmaceuticals Inc (OLMA) is -9.53 USD. This OLMA valuation is based on the model Peter Lynch Fair Value. With the current market price of 30.68 USD, the upside of Olema Pharmaceuticals Inc is -131.07%.
Based on its market price of 30.68 USD and our intrinsic valuation, Olema Pharmaceuticals Inc (OLMA) is overvalued by 131.07%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -9.53 - -9.53 | -9.53 | -131.07% |
| P/E | (38.97) - (43.28) | (44.04) | -243.5% |
| DDM - Stable | (10.93) - (28.95) | (19.94) | -165.0% |
| DDM - Multi | (8.33) - (17.61) | (11.36) | -137.0% |
| Market Cap (mil) | 2,413.29 |
| Beta | 0.47 |
| Outstanding shares (mil) | 78.66 |
| Enterprise Value (mil) | 2,381.03 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.07% |
| Cost of Debt | 5.00% |
| WACC | 8.37% |